socalTECH

MAY 12, 2014

Thousand Oaks-based seed biotechnology developer Ceres reports this morning that it has been awarded a U.S. patent on a genetic sequence derived from corn. The company said the patent, U.S. PTO, the inventors of the patent were Nicholai Alexandrov, Vyacheslav Brover, and Kenneth Feldman. According to the U.S.

Patents 147

Patents Thousand Oaks Research Report 147

socalTECH

APRIL 26, 2016

Thousand Oaks-based agricultural biotechnology developer Ceres reports that it hs received two, U.S. patents on crop traits that it says it is looking to apply to such crops as corn, soybean, forage sorghum and cotton. The two patents are U.S. 9,309,573, and bring the company's total number of patents to approximately 90.

Patents 100

Patents Thousand Oaks Report Develop 100

socalTECH

MAY 27, 2015

Thousand Oaks-based agricultural biotechnology develper Ceres announced this morning that it has received a U.S. patent, covering the company's genetic sequence derived from soybean, which is aimed at producing improved soybean varieties. The new patent, U.S. The new patent, U.S. ‌in the patent filing.

Patents 100

Patents Thousand Oaks Company Companies 100

socalTECH

JULY 18, 2011

Thousand Oaks-based Amgen said Friday afternoon that it has resolved a patent litigation suite with Teva. and Teva Pharmaceuticals USA, prohibiting them from infringing on its patents for human g-CSF.

Patents 124

Patents Thousand Oaks Product 124

socalTECH

FEBRUARY 26, 2019

Thousand Oaks-based Amgen has scored a win in court, after a jury upheld two patents held by the company for its drug Repatha, which is used to treat ultra-high LDL cholesterol. Amgen had been sued by Sanofi and Regeneron Pharmaceuticals over patent infringement.

Thousand Oaks 113

Thousand Oaks Patents Company Companies 113

socalTECH

JANUARY 7, 2020

Thousand Oaks-based Dyve Biosciences , a biotech company developing drug delivery technology, has named Chuck Harbert, Ph.D. Dyve said that Dr. Harbert is author or co-author of approximately twenty scientific publications and inventor or co-inventor of approximately thirty-five pharmaceutical patents, including ZOLOFT.

Thousand Oaks 100

Thousand Oaks Patents Develop Development 100

socalTECH

SEPTEMBER 28, 2017

Thousand Oaks-based Amgen and AbbVie have settled a series of lawsuits against each other, saying this morning that they have agreed to resolve all pending litigation regarding AMGEVITA/AMJEVITA, a biosimilar which is based on AbbVie's Humira (adalimumab).

Thousand Oaks 100

Thousand Oaks Patents Sales Product 100